Stryker Corporation
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replaceme…
Medical - Devices
US, Kalamazoo [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
1
Financial Health
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Current Ratio | 8.19 | 1.71 | 1.58 | |
| Debt/Assets | n.A. | n.A. | n.A. | |
| Debt/Equity | n.A. | n.A. | n.A. | |
| Net Debt/EBITDA | 3.93 | 6.86 | 6.60 | |
| Naive Interpretation | member | |||
2
Per Share
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 3.01 | 50.40 | 48.93 | |
| Cash | -21.24 | 6.33 | 8.03 | |
| Capex | -15.05 | -0.44 | -0.38 | |
| Free Cash Flow | -97.33 | 0.10 | 3.64 | |
| Revenue | -9.93 | 13.78 | 15.30 | |
| Naive Interpretation | member | |||
3
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Margin | -4.63 | 0.61 | 0.64 | |
| Operating Margin | -13.88 | 0.19 | 0.22 | |
| ROA | -30.17 | 0.02 | 0.03 | |
| ROE | -33.14 | 0.04 | 0.06 | |
| ROIC | -29.89 | 0.03 | 0.04 | |
| Naive Interpretation | member | |||
4
Valuation
The "Valuation Entry" for the Focus of SYK is permitted for members.
5
Growth
The "Growth Entry" for the Focus of SYK is permitted for members.
6
Leverage & Liquidity